xywav
Generic: calcium, magnesium, potassium, and sodium oxybates
xywav: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Phase 4 |
FDA Decisions
Approval(JAZZ)
Frequently asked questions
Who is developing xywav?
xywav is being developed by Jazz Pharmaceuticals plc.
What is xywav's latest FDA decision?
The most recent tracked FDA decision for xywav is Approval, dated July 21, 2020.
Get deeper analysis on xywav
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis